Annual Revenue
$370.00 M
+$369.56 M+84762.39%
31 December 2023
Summary:
CRISPR Therapeutics AG annual revenue is currently $370.00 million, with the most recent change of +$369.56 million (+84762.39%) on 31 December 2023. During the last 3 years, it has risen by +$369.46 million (+68039.96%). CRSP annual revenue is now -59.48% below its all-time high of $913.08 million, reached on 31 December 2021.CRSP Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
N/A
30 September 2024
Summary:
CRISPR Therapeutics AG quarterly revenue is not available.CRSP Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
N/A
30 September 2024
Summary:
CRISPR Therapeutics AG TTM revenue is not available.CRSP TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRSP Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +10000.0% | - | - |
| 3 y3 years | +10000.0% | - | - |
| 5 y5 years | +10000.0% | - | - |
CRSP Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -59.5% | >+9999.0% | ||||
| 5 y | 5 years | -59.5% | >+9999.0% | ||||
| alltime | all time | -59.5% | >+9999.0% |
CRISPR Therapeutics AG Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $370.00 M(>+9900.0%) | $200.00 M(+185.7%) | $370.00 M(+117.5%) |
| June 2023 | - | $70.00 M(-30.0%) | $170.10 M(+69.7%) |
| Mar 2023 | - | $100.00 M(>+9900.0%) | $100.26 M(>+9900.0%) |
| Dec 2022 | $436.00 K(-100.0%) | $6000.00(-93.6%) | $436.00 K(-96.6%) |
| Sept 2022 | - | $94.00 K(-40.5%) | $12.78 M(-1.8%) |
| June 2022 | - | $158.00 K(-11.2%) | $13.01 M(-98.6%) |
| Mar 2022 | - | $178.00 K(-98.6%) | $913.06 M(-0.0%) |
| Dec 2021 | $913.08 M(>+9900.0%) | $12.35 M(+3653.2%) | $913.08 M(+1.3%) |
| Sept 2021 | - | $329.00 K(-100.0%) | $900.93 M(+0.0%) |
| June 2021 | - | $900.20 M(>+9900.0%) | $900.75 M(>+9900.0%) |
| Mar 2021 | - | $202.00 K(+4.1%) | $588.00 K(+8.3%) |
| Dec 2020 | $543.00 K(-99.8%) | $194.00 K(+31.1%) | $543.00 K(-99.3%) |
| Sept 2020 | - | $148.00 K(+236.4%) | $77.36 M(-73.2%) |
| June 2020 | - | $44.00 K(-72.0%) | $289.14 M(-0.1%) |
| Mar 2020 | - | $157.00 K(-99.8%) | $289.42 M(-0.1%) |
| Dec 2019 | $289.59 M | $77.02 M(-63.7%) | $289.59 M(+36.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2019 | - | $211.93 M(>+9900.0%) | $212.69 M(>+9900.0%) |
| June 2019 | - | $318.00 K(-3.0%) | $1.32 M(-36.8%) |
| Mar 2019 | - | $328.00 K(+185.2%) | $2.09 M(-33.0%) |
| Dec 2018 | $3.12 M(-92.4%) | $115.00 K(-79.6%) | $3.12 M(-91.2%) |
| Sept 2018 | - | $563.00 K(-48.3%) | $35.33 M(-4.9%) |
| June 2018 | - | $1.09 M(-19.9%) | $37.16 M(-6.3%) |
| Mar 2018 | - | $1.36 M(-95.8%) | $39.65 M(-3.3%) |
| Dec 2017 | $41.00 M(+693.9%) | $32.33 M(+1254.2%) | $41.00 M(+272.2%) |
| Sept 2017 | - | $2.39 M(-33.4%) | $11.02 M(+8.2%) |
| June 2017 | - | $3.58 M(+32.5%) | $10.18 M(+37.7%) |
| Mar 2017 | - | $2.70 M(+15.3%) | $7.39 M(+43.1%) |
| Dec 2016 | $5.16 M(+1990.7%) | $2.34 M(+51.3%) | $5.16 M(+68.4%) |
| Sept 2016 | - | $1.55 M(+94.8%) | $3.07 M(+102.0%) |
| June 2016 | - | $795.00 K(+67.0%) | $1.52 M(+110.0%) |
| Mar 2016 | - | $476.00 K(+92.7%) | $723.00 K(+192.7%) |
| Dec 2015 | $247.00 K | $247.00 K | $247.00 K |
FAQ
- What is CRISPR Therapeutics AG annual revenue?
- What is the all time high annual revenue for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG annual revenue year-on-year change?
- What is the all time high quarterly revenue for CRISPR Therapeutics AG?
- What is the all time high TTM revenue for CRISPR Therapeutics AG?
What is CRISPR Therapeutics AG annual revenue?
The current annual revenue of CRSP is $370.00 M
What is the all time high annual revenue for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high annual revenue is $913.08 M
What is CRISPR Therapeutics AG annual revenue year-on-year change?
Over the past year, CRSP annual revenue has changed by +$369.56 M (+84762.39%)
What is the all time high quarterly revenue for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high quarterly revenue is $900.20 M
What is the all time high TTM revenue for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high TTM revenue is $913.08 M